Related Articles
Elsevier’s Oncology Journal Network Highlights | Elsevier
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Elsevier’s Oncology Journal Network Highlights | Elsevier
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Safety and efficacy of encorafenib–cetuximab combination in BRAFV600E-mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study
Dual blockade therapy encorafenib–cetuximab (EC) was recently established as the standard of care for second- or third-line treatment for BRAFV600E-mutated metastatic colorectal cancer (mCRC) patients…
Digital twins: a new paradigm in oncology in the era of big data
Recent advancements in health care digitalization opened the collection and availability of big data, whose analysis requires artificial intelligence-based technologies to facilitate the development of…
Real-world treatment patterns and challenges of patients with biliary tract cancer: retrospective chart review survey in Europe (GARNET-2)
Biliary tract cancers (BTCs), a heterogeneous group of cancers arising from the biliary tract, account for ∼15% of primary liver cancers. Patients are often diagnosed…
Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLC
Osimertinib has been the standard of care in epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC). We evaluated outcomes between osimertinib and first/second-generation (1G/2G)…
Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancer
Neoadjuvant chemotherapy (NAC) with the addition of pembrolizumab has become the standard of care for early-stage II-III triple-negative breast cancer (TNBC). The real-world safety of…
Home Page: ESMO Journals
Annals of Oncology Vol. 34 Issue 8 Annals of Oncology Vol. 34 Issue 8 Immuno-Oncology and Technology Vol. 19 Immuno-Oncology and Technology Vol. 19 Cancer…
Artificial intelligence for cancer screening and surveillance
Investing in cancer prevention can be cost-effective. However, this requires significant changes both inside and outside the health care system. The core of the preventive…
Elsevier’s Oncology Journal Network Highlights | Elsevier
Welcome to our Elsevier’s Oncology Journal Network Highlights page